Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles

被引:136
作者
Giusti, Ilaria [1 ]
D'Ascenzo, Sandra [1 ]
Millimaggi, Danilo [1 ]
Taraboletti, Giulia [1 ]
Carta, Gaspare [1 ]
Franceschini, Nicola [1 ]
Pavan, Antonio [1 ]
Dolo, Vincenza [1 ]
机构
[1] Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy
来源
NEOPLASIA | 2008年 / 10卷 / 05期
关键词
D O I
10.1593/neo.08178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vesicles shed by cancer cells are known to mediate several tumor-host interactions. Tumor microenvironment may, in turn, influence the release and the activity of tumor-shed microvesicles. In this study, we investigated the molecular mediators of the pH-dependent proinvasive activity of tumor-shed vesicles. Gelatinase zymography showed increased microvesicle activity of matrix metalloproteinases 9 and 2 as a result of acid exposure (pH 5.6) compared to pH 7.4. Thus, we reasoned that the cysteine protease cathepsin B might play a role in mediating the pH-dependent activation of gelatinases. Cathepsin B expression in tumor-shed microvesicles was confirmed by Western blot analysis and zymography. The activity of vesicle-associated cathepsin B measured using Z-Arg-Arg-pNA as substrate was significantly increased at acidic pH values. Inhibition of protease activity by the cysteine protease inhibitor, E-64, and treatment of ovarian cancer cells with small interfering RNA against cathepsin B suppressed the ability of tumor-shed microvesicles to stimulate both gelatinase activation and the invasiveness of endothelial cells observed at low pH values. We conclude that microvesicle shedding is a major secretory pathway for cathepsin B release from tumor cells. Hence, the acidic microenvironment found in most solid tumors may contribute to cathepsin B-mediated proinvasive capabilities of tumor-shed vesicles.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 46 条
[1]  
Albanese J, 1998, BLOOD, V91, P3862
[2]   Tumor-derived exosomes:: a new source of tumor rejection antigens [J].
André, F ;
Scharz, NEC ;
Chaput, N ;
Flament, C ;
Raposo, G ;
Amigorena, S ;
Angevin, E ;
Zitvogel, L .
VACCINE, 2002, 20 :A28-A31
[3]   Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines [J].
Angelucci, A ;
D'Ascenzo, S ;
Festuccia, C ;
Gravina, GL ;
Bologna, M ;
Dolo, V ;
Pavan, A .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) :163-170
[4]   DEGRADATION OF EXTRACELLULAR-MATRIX PROTEINS BY HUMAN CATHEPSIN-B FROM NORMAL AND TUMOR-TISSUES [J].
BUCK, MR ;
KARUSTIS, DG ;
DAY, NA ;
HONN, KV ;
SLOANE, BF .
BIOCHEMICAL JOURNAL, 1992, 282 :273-278
[5]   INVOLVEMENT OF A CATHEPSIN-B-LIKE CYSTEINE PROTEINASE IN PLATELET-AGGREGATION INDUCED BY TUMOR-CELLS AND THEIR SHED MEMBRANE-VESICLES [J].
CAVANAUGH, PG ;
SLOANE, BF ;
BAJKOWSKI, AS ;
GASIC, GJ ;
GASIC, TB ;
HONN, KV .
CLINICAL & EXPERIMENTAL METASTASIS, 1983, 1 (04) :297-307
[6]   Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease [J].
Dickinson, DP .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (03) :238-275
[7]  
Dolo V, 1997, ONCOL RES, V9, P129
[8]  
Dolo V, 1998, CANCER RES, V58, P4468
[9]  
DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173
[10]   Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro [J].
Dolo, V ;
D'Ascenzo, S ;
Violini, S ;
Pompucci, L ;
Festuccia, C ;
Ginestra, A ;
Vittorelli, ML ;
Canevari, S ;
Pavan, A .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (02) :131-140